- Home
- GALT vs FCT Comparison
GALT vs FCT Comparison
Compare GALT & FCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- FCT
- Stock Information
- Founded
- GALT 2000
- FCT 2004
- Country
- GALT United States
- FCT United States
- Employees
- GALT N/A
- FCT N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- FCT Finance Companies
- Sector
- GALT Health Care
- FCT Finance
- Exchange
- GALT Nasdaq
- FCT Nasdaq
- Market Cap
- GALT 232.3M
- FCT 265.0M
- IPO Year
- GALT N/A
- FCT N/A
- Fundamental
- Price
- GALT $4.60
- FCT $10.11
- Analyst Decision
- GALT Strong Buy
- FCT
- Analyst Count
- GALT 3
- FCT 0
- Target Price
- GALT $6.00
- FCT N/A
- AVG Volume (30 Days)
- GALT 241.8K
- FCT 106.8K
- Earning Date
- GALT 08-14-2025
- FCT 01-01-0001
- Dividend Yield
- GALT N/A
- FCT 11.29%
- EPS Growth
- GALT N/A
- FCT N/A
- EPS
- GALT N/A
- FCT N/A
- Revenue
- GALT N/A
- FCT N/A
- Revenue This Year
- GALT N/A
- FCT N/A
- Revenue Next Year
- GALT N/A
- FCT N/A
- P/E Ratio
- GALT N/A
- FCT N/A
- Revenue Growth
- GALT N/A
- FCT N/A
- 52 Week Low
- GALT $0.73
- FCT $9.45
- 52 Week High
- GALT $4.71
- FCT $10.42
- Technical
- Relative Strength Index (RSI)
- GALT 69.41
- FCT 47.74
- Support Level
- GALT $3.93
- FCT $10.05
- Resistance Level
- GALT $4.35
- FCT $10.24
- Average True Range (ATR)
- GALT 0.27
- FCT 0.08
- MACD
- GALT 0.03
- FCT -0.00
- Stochastic Oscillator
- GALT 91.67
- FCT 38.10
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest
First Trust Senior Floating Rate Income Fund II is a United States-based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, it attempts to preserve capital. The fund invests in a portfolio of senior secured floating-rate corporate loans (Senior Loans) of companies from different industries, such as Insurance, Software, Health Care Providers and Services, Professional Services, Health Care Technology, IT Services, and others.